The first batch of basic drugs in Guangdong has been determined, and the demand for exclusive varieties of traditional Chinese medicine is large

Source: great wisdom astak news agency took a substantial step in the mode of Guangdong drug exchange on January 21, 2014 The total procurement volume of the first batch of basic drugs for medical institutions was announced on the platform, and the bidding rule of "volume procurement" was implemented Today, big smart news agency got the first round of summary of the planned purchase quantity of medical institutions from the inside of the enterprise, and found that the demand for exclusive varieties is large, and pharmaceutical enterprises such as Tianshili and Zhongsheng pharmaceutical may become big winners In the list of the first batch of basic drugs, the top ten varieties are all exclusive varieties of traditional Chinese medicine Among them, Tianshili's Compound Danshen dropping pill, Zhongsheng pharmaceutical's compound Xueshuantong capsule and Changbu pharmaceutical's Naoxintong all rank in the top of the list Volume procurement is a key point of Guangdong drug exchange model It means that on the basis of centralized bidding procurement at the provincial level, hospitals or medical consortia "group purchase" mode is adopted to define the type, quantity and price of procurement, and link the volume and price to obtain the lowest procurement price In the view of pharmaceutical companies, this is to trade price for quantity, with the aim of reducing price A person in charge of bidding in Southwest China told the big wisdom news agency that the exclusive varieties are also very strong in the hospital terminal, and the strategies adopted can be various, and the annual volume can be reported, which can prevent the medical institutions from changing other products in the same department; the component reported to the department needs to be maintained by the terminal operator However, in any case, the exclusive variety can be well maintained in terms of quantity and price "In fact, the purchase volume of this round is not a lot in general," a local enterprise bidding personnel told the big smart news agency, "after all, this is the first time to operate in the drug exchange mode, and the hospital will be relatively cautious, too many reports, and failure to purchase according to the plan may affect the hospital performance." The person in charge of bidding in Southwest China said from the perspective of enterprises that pharmaceutical enterprises should start from the terminal and try not to purchase as much as possible They should wait and see first, and then make decisions later, "because if they don't, other competitive enterprises are not willing to cut prices to seize the market.".